Selecta Biosciences' Series C Round

Selecta Biosciences raised a round of funding on March 08, 2010.

Selecta Biosciences is a biopharmaceutical company developing a new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic a…

Articles about Selecta Biosciences' Series C Round: